查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1685067

胃內水球市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

Intragastric Balloon Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年全球胃內水球市場價值為 6,850 萬美元，預計 2025 年至 2034 年期間的複合年成長率為 14.8%。推動這一成長的因素包括技術進步、人們對肥胖相關健康風險認知的提高以及醫療支持和保險覆蓋範圍的擴大。全球肥胖症的日益流行，使得越來越多的人尋求非手術減肥方法，從而推動了胃內水球的需求。這些裝置旨在幫助患者感覺更飽腹，從而減少食物攝入，為外科手術提供了微創的替代方案。它們的成本相對較低，加上設計和可用性的不斷改進，提高了它們的有效性以及對醫療保健提供者和患者的吸引力。

胃內水球市場 - IMG1

隨著肥胖率的上升，對有效減肥介入的需求從未如此強烈。傳統的減肥方法，包括節食和運動，往往無法帶來長期效果，促使人們探索替代解決方案。胃內水球在生活方式改變和外科手術之間架起了一座有效的橋樑，為體重管理提供了一個臨時但有效的解決方案。此外，越來越多的醫療專業人士的認可，加上積極的患者體驗，正在推動市場成長。隨著消費者對自己的選擇越來越了解，對非侵入性減肥治療的偏好不斷上升，這使得胃內水球市場有望大幅擴張。隨著肥胖率不斷上升，新興經濟體擴大採用這些設備，這進一步凸顯了該市場的長期潛力。正在進行的研究和開發工作旨在增強球囊的耐用性、提高患者的舒適度、延長治療時間，確保產業持續成長。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 6850 萬美元
預測值 2.684 億美元
複合年成長率 14.8％

市場按產品類型細分，包括單胃內球囊、雙胃內球囊和三胃內球囊。 2024年，單一胃內球囊部分創收4,120萬美元。這些氣球之所以受到青睞是因為它們易於部署，提供了一個簡單的插入過程，可減少手術時間和併發症風險。由於其簡單性，它們成為患者和醫療保健提供者的首選，特別是因為它們提供了雙氣囊系統的經濟高效的替代方案。隨著人們越來越重視可及性，單一胃內水球繼續佔據市場主導地位，提供經濟實惠且高效的減肥解決方案。

市面上的給藥方式包括內視鏡和藥丸形式，其中內視鏡方法在 2024 年佔據領先地位，佔有 74.3% 的佔有率。該技術涉及使用內視鏡將氣囊插入胃中，無需切口或縫合。作為一種微創選擇，它降低了風險並縮短了恢復時間，對於尋求高效、低風險減肥方法的人來說是一個有吸引力的選擇。內視鏡球囊置入術的便利性和安全性極大地促進了其被廣泛採用，醫療機構擴大推薦它作為肥胖患者的主要干預措施。

2024 年，美國胃內水球市場價值為 2,490 萬美元，預計到 2034 年將以 14.8% 的複合年成長率成長。美國食品藥物管理局 (FDA) 對這些設備的批准，對於增強消費者信心、確保患者和醫療保健提供者認知到其安全性和有效性起到了重要作用。 FDA 的批准在提高採用率方面發揮了至關重要的作用，越來越多的人將這些產品納入他們的減肥策略中。美國消費者越來越尋求侵入性更小、恢復期更短、併發症更少的治療方法，這進一步加速了市場的擴張。隨著對創新和非手術減肥解決方案的需求不斷成長，預計未來幾年美國胃內水球市場將實現強勁且持續的成長。

目錄

第 1 章：方法論與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業衝擊力
    • 成長動力
      • 肥胖盛行率上升
      • 人們對微創手術的偏好日益增加
      • 技術進步
    • 產業陷阱與挑戰
      • 副作用和併發症的風險
  • 成長潛力分析
  • 監管格局
  • 技術格局
  • 報銷場景
  • 波特的分析
  • PESTEL 分析
  • 差距分析
  • 價值鏈分析

第4章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 策略儀表板

第5章：市場估計與預測：按產品，2021 — 2034 年

  • 主要趨勢
  • 單胃內球囊
  • 雙胃內水球
  • 三重胃內水球

第6章：市場估計與預測：按填充材料，2021 年至 2034 年

  • 主要趨勢
  • 鹽水球囊
  • 充氣氣球

第7章：市場估計與預測：依政府分類，2021 年至 2034 年

  • 主要趨勢
  • 內視鏡檢查
  • 藥丸形式

第 8 章：市場估計與預測：依最終用途，2021 年至 2034 年

  • 主要趨勢
  • 醫院
  • 門診手術中心
  • 專科診所
  • 其他最終用戶

第 9 章：市場估計與預測：按地區，2021 年至 2034 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第10章：公司簡介

  • Allurion
  • Boston Scientific (Apollo Endosurgery)
  • districlass medical
  • endalis
  • HEALTH WARE
  • helioscopie
  • Medicone
  • medispar
  • OBALON
  • ReShape Lifesciences
  • SHENYUN
  • SILIMED
  • SPATZ
簡介目錄
Product Code: 1173

The Global Intragastric Balloon Market, valued at USD 68.5 million in 2024, is expected to expand at a CAGR of 14.8% from 2025 to 2034. This surge is driven by advancements in technology, increasing awareness of obesity-related health risks, and greater access to medical support and insurance coverage. The growing prevalence of obesity worldwide has led more individuals to seek non-surgical weight-loss solutions, fueling demand for intragastric balloons. These devices, designed to help patients feel fuller and consume less food, offer a minimally invasive alternative to surgical procedures. Their relatively low cost, coupled with continuous improvements in design and usability, has enhanced their effectiveness and appeal among both healthcare providers and patients.

Intragastric Balloon Market - IMG1

With rising obesity rates, the need for effective weight-loss interventions has never been greater. Traditional weight-loss methods, including diet and exercise, often fail to deliver long-term results, prompting individuals to explore alternative solutions. Intragastric balloons provide an effective bridge between lifestyle modifications and surgical procedures, offering a temporary yet impactful solution for weight management. Additionally, growing endorsements from medical professionals, coupled with positive patient experiences, are propelling market growth. As consumers become more informed about their options, the preference for non-invasive weight-loss treatments continues to rise, positioning the intragastric balloon market for significant expansion. The increasing adoption of these devices in emerging economies, where obesity rates are climbing, further underscores the market's long-term potential. Ongoing research and development efforts aim to enhance balloon durability, improve patient comfort, and extend treatment duration, ensuring sustained growth in the industry.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$68.5 Million
Forecast Value$268.4 Million
CAGR14.8%

The market is segmented by product type, with single, dual, and triple intragastric balloons available. In 2024, the single intragastric balloon segment generated USD 41.2 million. These balloons are preferred due to their ease of deployment, offering a straightforward insertion process that reduces both procedure time and complication risks. Their simplicity makes them the top choice for both patients and healthcare providers, particularly as they offer a cost-effective alternative to dual-balloon systems. With an increasing focus on accessibility, single intragastric balloons continue to dominate the market, providing an affordable yet highly effective weight-loss solution.

Administration methods in the market include endoscopic and pill forms, with the endoscopic method leading in 2024, holding a 74.3% share. This technique involves inserting the balloon into the stomach using an endoscope, eliminating the need for incisions or stitches. As a minimally invasive option, it reduces risks and recovery time, making it an attractive choice for individuals seeking efficient and low-risk weight-loss procedures. The convenience and safety profile of endoscopic balloon placement has significantly contributed to its widespread adoption, with healthcare facilities increasingly recommending it as a primary intervention for patients struggling with obesity.

The intragastric balloon market in the United States was valued at USD 24.9 million in 2024 and is projected to grow at a 14.8% CAGR through 2034. The U.S. Food and Drug Administration (FDA) approval of these devices has been instrumental in boosting consumer confidence, ensuring patients and healthcare providers recognize their safety and effectiveness. FDA clearance has played a crucial role in increasing adoption, with more individuals incorporating these products into their weight-loss strategies. American consumers are increasingly seeking less invasive treatments with shorter recovery periods and fewer complications, further accelerating the market's expansion. As the demand for innovative and non-surgical weight-loss solutions grows, the intragastric balloon market in the United States is expected to witness robust and sustained growth over the coming years.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of obesity
      • 3.2.1.2 Growing preference for minimally invasive procedures
      • 3.2.1.3 Technological advancements
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Risk of side effects and complications
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
  • 3.6 Reimbursement scenario
  • 3.7 Porter’s analysis
  • 3.8 PESTEL analysis
  • 3.9 Gap analysis
  • 3.10 Value chain analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 — 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Single intragastric balloon
  • 5.3 Dual intragastric balloon
  • 5.4 Triple intragastric balloon

Chapter 6 Market Estimates and Forecast, By Filling Material, 2021 — 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Saline-filled balloon
  • 6.3 Gas-filled balloon

Chapter 7 Market Estimates and Forecast, By Administration, 2021 — 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Endoscopy
  • 7.3 Pill form

Chapter 8 Market Estimates and Forecast, By End Use, 2021 — 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Ambulatory surgical centers
  • 8.4 Specialty clinics
  • 8.5 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2021 — 2034 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 Allurion
  • 10.2 Boston Scientific (Apollo Endosurgery)
  • 10.3 districlass medical
  • 10.4 endalis
  • 10.5 HEALTH WARE
  • 10.6 helioscopie
  • 10.7 Medicone
  • 10.8 medispar
  • 10.9 OBALON
  • 10.10 ReShape Lifesciences
  • 10.11 SHENYUN
  • 10.12 SILIMED
  • 10.13 SPATZ